• bitcoinBitcoin(BTC)$78,822.00-1.43%
  • ethereumEthereum(ETH)$2,478.20-1.12%
  • tetherTether(USDT)$1.00-0.02%
  • binancecoinBNB(BNB)$736.51-1.91%
  • rippleXRP(XRP)$1.39-2.47%
  • usd-coinUSDC(USDC)$1.00-0.01%
  • solanaSolana(SOL)$103.33-2.41%
  • tronTRON(TRX)$0.334092-0.40%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.060.00%
  • zcashZcash(ZEC)$1,123.55-8.14%
  • HyperliquidHyperliquid(HYPE)$84.77-2.83%
  • dogecoinDogecoin(DOGE)$0.089830-0.57%
  • RainRain(RAIN)$0.016276-2.94%
  • USDSUSDS(USDS)$1.00-0.02%
  • moneroMonero(XMR)$513.51-4.41%
  • chainlinkChainlink(LINK)$12.65-2.51%
  • whitebitWhiteBIT Coin(WBT)$76.283.53%
  • leo-tokenLEO Token(LEO)$9.20-1.76%
  • cardanoCardano(ADA)$0.217441-1.83%
  • stellarStellar(XLM)$0.1908232.49%
  • bitcoin-cashBitcoin Cash(BCH)$256.18-1.04%
  • daiDai(DAI)$1.000.01%
  • Ethena USDeEthena USDe(USDE)$1.00-0.02%
  • litecoinLitecoin(LTC)$55.080.82%
  • USD1USD1(USD1)$1.000.00%
  • uniswapUniswap(UNI)$6.78-5.67%
  • CantonCanton(CC)$0.105104-3.67%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.39-2.92%
  • hedera-hashgraphHedera(HBAR)$0.0815360.33%
  • avalanche-2Avalanche(AVAX)$8.052.65%
  • suiSui(SUI)$0.810.28%
  • Global DollarGlobal Dollar(USDG)$1.000.00%
  • shiba-inuShiba Inu(SHIB)$0.000005-1.98%
  • nearNEAR Protocol(NEAR)$2.28-6.72%
  • paypal-usdPayPal USD(PYUSD)$1.00-0.02%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • crypto-com-chainCronos(CRO)$0.056509-1.61%
  • tether-goldTether Gold(XAUT)$4,405.52-0.37%
  • Circle USYCCircle USYC(USYC)$1.140.00%
  • MemeCoreMemeCore(M)$1.152.08%
  • BittensorBittensor(TAO)$256.08-2.41%
  • Ripple USDRipple USD(RLUSD)$1.00-0.01%
  • okbOKB(OKB)$115.772.26%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.150.01%
  • AsterAster(ASTER)$0.77-2.59%
  • mantleMantle(MNT)$0.622.50%
  • aaveAave(AAVE)$130.73-2.83%
  • pax-goldPAX Gold(PAXG)$4,408.32-0.39%
  • OndoOndo(ONDO)$0.379768-0.73%
  • World Liberty FinancialWorld Liberty Financial(WLFI)$0.056194-0.75%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

OpenAI Releases LifeSciBench, a 750-Task Benchmark Grading AI Models on Real Life-Science Research With Expert-Written Rubric

June 18, 2026
in AI & Technology
Reading Time: 6 mins read
A A
OpenAI Releases LifeSciBench, a 750-Task Benchmark Grading AI Models on Real Life-Science Research With Expert-Written Rubric
ShareShareShareShareShare

Most biology benchmarks ask narrow, fact-based questions with clean answers. Scientists weigh imperfect evidence and make decisions. OpenAI released LifeSciBench and it targets that gap directly.

Even the strongest model passes roughly one task in three. The benchmark is far from saturated.

YOU MAY ALSO LIKE

6 Ways To Make The Most Out Of Your Apple Wallet

Capcom Is Reviving More Dormant Franchises After The Success Of Onimusha: Way Of The Sword

What is LifeSciBench

LifeSciBench contains 750 expert-authored tasks. They span seven workflows and seven biological domains. Each task pairs a prompt, supporting artifacts, and a grading rubric.

The seven workflows cover evidence handling and analysis. They also include design and optimization, scientific reasoning, validation and operations, translation, and scientific communication.

The seven domains run from genomics and medicinal chemistry to clinical and translational science.

Tasks are written as a scientist would brief a colleague. They are free-response, not multiple-choice. Around 79% require multiple reasoning or decision-making steps, averaging four steps each.

How the Benchmark was Built

A cohort of 173 expert scientists wrote the tasks. Each held a Ph.D. and had biotechnology or pharmaceutical experience. Accepted tasks averaged six automated review cycles and at least two expert reviews.

Many tasks ship with artifacts. The benchmark includes 1,062 attached artifacts in total. About 53% of tasks require at least one artifact. Types include sequences, figures, tables, PDFs, and chemical structures.

A separate cohort validated quality. There were 453 reviewers, and 97% held doctorates. Overall agreement exceeded 96% on relevance, reasoning, grounding, and usefulness.

The Rubric System

Rubrics are the core mechanic here. They contain 19,020 criteria across the benchmark. That is roughly 25 criteria per task.

Each criterion rewards one concrete property. Examples include a specific fact, a reasoning step, or a numeric answer within tolerance. Grading runs against the rubric, not a single reference string.

Two metrics summarize performance. Normalized rubric score divides awarded points by total points. Task pass rate counts tasks scoring at or above 70%.

This separation matters for interpretation. A response can earn partial credit while still failing the task. The pass threshold is strict by design.

Here is the scoring logic in plain Python:

def grade(rubric, awarded_ids):
    total = sum(c["pts"] for c in rubric)
    earned = sum(c["pts"] for c in rubric if c["id"] in awarded_ids)
    normalized = earned / total          # partial credit
    passed = normalized >= 0.70          # task-level success
    return normalized, passed

How the Models Performed

OpenAI evaluated five models in a single-turn setting. Each model saw the prompt and artifacts once. Unrestricted internet browsing was permitted.

Model Normalized score Task pass rate
GPT-Rosalind 0.576 36.1%
GPT-5.5 0.519 25.7%
Gemini 3.1 Pro 0.515 23.6%
GPT-5.4 0.479 20.7%
Grok 4.3 0.399 13.0%

GPT-Rosalind, OpenAI’s domain-specialized model, led overall. It had the highest per-task mean on 386 of 750 tasks. It also lifted the overall pass rate over GPT-5.5, from 25.7% to 36.1%. Pass rates stayed modest across every model.

Rankings are not the whole story. Gemini 3.1 Pro uniquely led on 214 tasks. Aggregate scores can hide task-specific strengths.

Where Models Win, and Where They Fall Short

Models were strongest on structured judgment. GPT-Rosalind reached a 0.712 mean score on Translation. Scientific Communication scored 0.718, but that category is small, so read it cautiously.

Two workflows stayed hard. Design, Optimization, and Prediction was among the toughest, with GPT-Rosalind passing 30.7%. Analysis was close behind at 30.3%.

Artifact use was a clear bottleneck. GPT-Rosalind dropped from 45.1% on text-only tasks to 28.1% on artifact tasks. GPT-5.5 fell the same way, from 29.9% to 21.9%.

Exact outputs were hardest of all. Sequence and structure criterion success ranged from 46.9% to 18.0% across models. GPT-Rosalind’s gain over GPT-5.5 on generate/construct items was just +0.001.

Models also stalled mid-task. For GPT-Rosalind, 109 tasks earned at least 50% rubric credit but still passed below 20%.

Headroom remains large. No model passed 171 tasks (22.8%). And 261 tasks (34.8%) had a best-model pass rate below 20%.

Strengths and Weaknesses

Strengths:

  • Broad coverage across seven workflows and seven biological domains
  • Expert-authored rubrics with 19,020 atomic, gradeable criteria
  • Realistic artifacts: sequences, figures, tables, PDFs, and structures
  • Independent validation by 453 expert reviewers, 97% with doctorates

Weaknesses:

  • Single-turn only; real research is iterative and multi-turn
  • Built by OpenAI, which also supplies most evaluated models
  • Public release may be limited by safety and licensing constraints
  • 750 tasks cannot cover every scientific specialty

Try It: Interactive Rubric Grader Demo






LifeSciBench — Interactive Demo

Rubric Grader & Model Leaderboard

See how rubric-based grading works on a real benchmark task. Toggle the criteria a model “got right” and watch the normalized score and 70% pass threshold update live.


Task (Analysis — Spatial Transcriptomics): Using attached Visium data from an FFPE cervical cancer slide, cluster the spots into 4 k-means groups, annotate the dominant cell type per cluster, and recommend the 1–2 most promising targeted therapies (ADC, TCE, or CAR-T) based on antigen expression differences between tumor and non-tumor regions.

Simulate a response:



0 / 76 pts

Normalized score: 0%

▲ 70% pass threshold (53.2 pts)

FAIL — below 70%

A response can collect partial credit yet still fail the task. That gap is exactly what LifeSciBench measures.


Single-turn evaluation; unrestricted internet browsing permitted. GPT-Rosalind led overall but uniquely topped only 386 of 750 tasks; Gemini 3.1 Pro uniquely led on 214.


Check out the Paper and Technical details. Also, feel free to follow us on Twitter and don’t forget to join our 150k+ML SubReddit and Subscribe to our Newsletter. Wait! are you on telegram? now you can join us on telegram as well.

Need to partner with us for promoting your GitHub Repo OR Hugging Face Page OR Product Release OR Webinar etc.? Connect with us


Michal Sutter is a data science professional with a Master of Science in Data Science from the University of Padova. With a solid foundation in statistical analysis, machine learning, and data engineering, Michal excels at transforming complex datasets into actionable insights.

Credit: Source link

ShareTweetSendSharePin

Related Posts

6 Ways To Make The Most Out Of Your Apple Wallet
AI & Technology

6 Ways To Make The Most Out Of Your Apple Wallet

September 7, 2026
Capcom Is Reviving More Dormant Franchises After The Success Of Onimusha: Way Of The Sword
AI & Technology

Capcom Is Reviving More Dormant Franchises After The Success Of Onimusha: Way Of The Sword

September 7, 2026
OpenBMB Releases MiniCPM5-2B: A 2.52B Dense Model Averaging 53.9 Across 34 Benchmarks and Built to Run On Device
AI & Technology

OpenBMB Releases MiniCPM5-2B: A 2.52B Dense Model Averaging 53.9 Across 34 Benchmarks and Built to Run On Device

September 7, 2026
When Is It No Longer Worth Repairing Your Phone And Buying A New One Instead
AI & Technology

When Is It No Longer Worth Repairing Your Phone And Buying A New One Instead

September 7, 2026
Next Post
Amkor Technology Stock: Strong AI Story But No Longer Cheap (NASDAQ:AMKR)

Amkor Technology Stock: Strong AI Story But No Longer Cheap (NASDAQ:AMKR)

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Infant died of measles in Pennsylvania, coroner confirms – The Washington Post

Infant died of measles in Pennsylvania, coroner confirms – The Washington Post

September 5, 2026
Pennsylvania’s measles crisis: Inside the nation’s largest outbreak – Pittsburgh Post-Gazette

Pennsylvania’s measles crisis: Inside the nation’s largest outbreak – Pittsburgh Post-Gazette

September 6, 2026
Berlin police kill suspect in Pride festival attack after manhunt

Berlin police kill suspect in Pride festival attack after manhunt

September 4, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!